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In this issue of ATVB, Ueland et al and Zue et al are reporting the prognostic value for future cardiovascular events of el-
evated serum levels of DKK1 (Dickkopf 1) at admission in 
patients with acute myocardial infarction or ischemic stroke, 
respectively.1,2 Raised DKK1 levels were previously reported 
in smaller patient cohorts with type 2 diabetes mellitus and 
cardiovascular disease or in acute ischemic stroke patients.3,4 
Nevertheless, these studies did not excite major attention be-
cause of their relatively small cohorts and because they did 
not consider the prognostic value of elevated DKK1 for fu-
ture cardiovascular events. The newly published studies in this 
journal have significantly more patients, which were followed 
up after their first cardiovascular event for recurrent cardio-
vascular events, making these cohorts valuable for assessing 
whether DKK1 is a potential biomarker for unstable athero-
sclerotic arterial disease.
See accompanying articles on pages 285 and 294
The secreted glycoprotein DKK1, a member of the 
Dickkopf family, is known to antagonize Wnt/β-signaling by 
interaction with the LRP5/6 (low-density lipoprotein receptor-
related protein 5/6). The Wnt/β-catenin signaling pathway is 
an important mediator in cardiovascular disease and influ-
ences inflammation, vascular calcification, and proliferation 
of different cell types in atherosclerotic disease.5 DKK1 plays 
an important role in vertebrate embryogenesis and knocking 
out of the DKK1 gene leads to impaired limb and head de-
velopment in mice.6 The first step to induce Wnt/β-signaling 
is the interaction of Wnt proteins with a receptor complex on 
the plasma membrane, consisting of a member of the Frizzled 
protein family and its co-receptor LRP5/6. The intracellular 
signal transducing protein β-catenin, which normally is de-
graded in the cell (Figure [A]), consequently accumulates, 
leading to the transcription of multiple target genes (Figure 
[B]). The protein structure of LRP5/6 consists of 4 β-propeller 
domains connected to a transmembrane region.7,8 DKK1 binds 
with high affinity to the first and third β-propeller structure, 
which also harbors the binding site for Wnt proteins, and 
consequently abolishes the signaling via the Wnt/β-catenin 
cascade.5,9 Furthermore, Kremen receptors act together with 
DKK1 to induce endocytosis of LRP5/610 (Figure [C]). 
Despite structural similarities between LRP5 and LRP6, both 
seem to have slightly different roles in the Wnt/β-catenin sig-
naling pathway. LRP6 is involved in embryonal development, 
adult bone formation, and was recently reported to also play 
a role in LDL clearance.5,11 Moreover, mutations of LRP6 are 
strongly associated with cardiovascular disease.5 For example, 
the LRP6
R611C
 mutation strongly affects cholesterol biosyn-
thesis and LDL clearance resulting in high LDL and triglyc-
eride serum levels, which are one of the major risk factors for 
cardiovascular disease.11 Knockout of LRP6 in ApoE−/− mice 
led to postnatal lethality.12 Mutations of LRP5 are associated 
with an early onset of osteoporosis, an abnormal increase of 
bone mass, and calcified aortic valves.5,13,14 In addition, total 
knockout of LRP5 in mice leads to abnormal low bone mass.5
Many different molecular mechanisms and structural 
changes are responsible for the formation of unstable athero-
sclerotic plaques. This includes inflammation, the loss of vas-
cular smooth muscle cells (VSMC), the size of the necrotic core, 
and microcalcifications in the fibrous cap.15,16 Atherosclerotic 
plaque heterogeneity in terms of cell contribution and mor-
phology further raises the complexity of this field.17 Oxidized 
LDL induces the expression of DKK1 in macrophages and in 
endothelial cells.18,19 Furthermore, the presence of monocytes/
macrophages and oxidized LDL led to a higher matrix metal-
loproteinase activity in calcifying vascular cells, causing fur-
ther instability of the atherosclerotic plaque.20 On the contrary, 
downregulation of DKK1 impaired monocyte adhesion to endo-
thelial cells and, therefore, attenuated inflammation of the ath-
erosclerotic plaque.21 Oscillating shear stress, often present in 
branches and curves of large arteries, induces DKK1 expression 
in vitro in a shear stress model with endothelial cells as well as in 
ApoE−/− mice.21 Overexpression of DKK1 in ApoE−/− mice led to 
enlarged plaque formation and promoted instability of the lesion, 
because of enhanced apoptosis of endothelial cells. Endothelial 
cells, macrophages, and platelets are sources of DKK1, whereas 
VSMC does not secrete DKK112. Interestingly, in co-cultures 
with endothelial cells, VSMC tend to take up DKK1 and prolif-
eration of VSMC was inhibited by recombinant DKK1.19,22 On 
the contrary, DKK1 seems to correlate negatively with the se-
verity of vascular calcification in patients.23–25 There is plausible 
evidence that sheet-like calcifications have a stabilizing effect 
on the atherosclerotic plaque, whereas spotty calcification or 
microcalcification are often associated with unstable plaques.26 
In vitro studies showed that DKK1 was able to attenuate RUNX2 
(runt-related transcription factor 2) expression in VSMC, which 
is an important transcription factor for osteogenic differentia-
tion of VSMC. Additionally, the Frizzled protein/LRP6 agonist 
Wnt3a, promoted the calcification process.27
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In summary, there is convincing evidence that DKK1 is ele-
vated in unstable compared with stable atherosclerotic plaques. 
It is tempting to speculate that DKK1 promotes unstable plaque 
formation by inhibiting the deposition of protective larger cal-
cifications and through influencing the cellular plaque compo-
sition. Moreover, DKK1 seems to be a promising biomarker 
candidate to predict future cardiovascular and cerebrovascular 
events. Consequently, including the admission DKK1 serum 
levels in the assessment of patients hospitalized with myocar-
dial infarction or stroke could help to identify those at highest 
risk of further cardiovascular events. Nevertheless, further re-
search will be needed to clarify the role of DKK1—and Wnt 
signaling in general—in maintaining plaque stability.
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